December 20, 2011
Bucks: BrightScope's Top-Rated 401K Plans for 2011
The New York Times, Tara Siegel Bernard

December 8, 2011
Q&A: William Sellers on Success in Small Molecules
Cancer Discovery, Eric Bender

December 8, 2011
Novartis complex to fuse art, technology
Boston Globe

December 6, 2011
Novartis to shut brain research facility
Alison Abbott, Nature

November 22, 2011
Top five ways Big Pharma can address neglected diseases
By Sarika Bansal - Forbes blog

November 18, 2011
New Malaria Drugs Stop Parasite Early Animal tests promising, but human trials still ahead
By Art Chimes - Voice of America

November 17, 2011
New Antimalaria Treatment Holds Promise As Prophylactic
By Goran Mijuk - Dow Jones Newswires (also appeared on Wall Street Journal)

November 17, 2011
Novartis Malaria Medicine Kills Bugs at Earliest Stage, Study Shows
By Simeon Bennett - Bloomberg

November 7, 2011
Islands of economic growth
By Casey Ross - The Boston Globe

October 17, 2011
A Quest for More Effective Drugs
By Carolyn Y. Johnson - The Boston Globe

October 5, 2011
Education: Inspiration for informatics
Nature, Virginia Gewin

September 27, 2011
Novartis & Pfizer to move near campus
MIT The Tech

September 13, 2011
Betting big on research in China
By Nick Stephens - InPharm

September 13, 2011
On a winning streak, Novartis maps bullish ophthalmology R&D strategy
By John Carroll - Fierce Biotech

September 8, 2011
Novartis International BioCamp Inspires Future Science Leaders
by CSR Wire

September 7, 2011
Mogul Using $100 Million in Race to Cure Daughter Lures Novartis
by Robert Langreth and Alex Nussbaum - Bloomberg Businessweek

August 2011
Autism Poses Drug R and D Challenges
by Fierce BioTech

August 18, 2011
EBI2: The Race is On – Autoimmune Disease
by Chris Cain, SciBX

August 3, 2011
The Best Drug Companies Of The Decade
by Matthew Herper, Forbes Staff

August 2011
Make Mine Rare -- Bio Business
by Megan Scudelarri, The Scientist

July 15, 2011
Psoriasis:from bench to bed and back
by Ken Garber - Nature BioTechnology

June 17, 2011
Advancing in Industry: Choosing Among Many Paths Embracing Collaboration
by Science, Laura Bonetta

June 3, 2011
Corporate Partner Novartis Enhances Science for Cristo Rey
by CRB News

June 1, 2011
Emerging Pharma Leaders 2011: Jennifer Leeds, Head of Antibacterial Discovery Infectious Diseases Area, Novartis
by Pharmaceutical Executive

June 1, 2011
To Screen or Not to Screen? The Current State of Global Health Equity
by Ben Comer - Pharmaceutical Executive

May 12, 2011
Cancer Sleuths Uncovering DNA Mysteries for Novartis, Glaxo
by Robert Langreth - Bloomberg Businessweek

May 4, 2011
Drug makers see gains in broadening their reach
by Robert Weisman - The Boston Globe

May 2010
A Different Kind of Postdoc Experience
by Amber Dance - Howard Hughes Medical Institute Digest

May 2010
Best Places to Work Industry, 2011
by Hannah Waters - The Scientist

April 8, 2011
Don't Talk to Me About Financials, Says Novartis R&D Head
by Shirley S. Wang - Wall Street Journal Health Blog

April 4, 2011
Novartis CEO vowing to back ambitious $8B R&D strategy
by John Carroll - Fierce Biotech

March 21, 2011
Novartis #1 pharmaceutical in Fortune's World's Most Admired Companies 2011
by Fortune

March 10, 2011
From Soup to MS Drug: One Fungus's Journey
by Kanoko Matsuyama - Bloomberg Businessweek

February 14, 2011
Notable People in R&D: Volker Brinkmann, Autoimmunity, Transplantation and Inflammation
by Michael D. Christel - R&D Directions

February 2011
The 50 Most Innovative Companies 2011
by MIT Technology Review

January 4, 2011
At Novartis, a winning formula
by The Boston Globe - Robert Weisman